Identification of amino acids in the nicotinic acetylcholine receptor agonist binding site and ion channel photolabeled by 4-[(3-trifluoromethyl)-3H-diazirin-3-yl]benzoylcholine, a novel photoaffinity antagonist

被引:18
|
作者
Chiara, DC [1 ]
Trinidad, JC [1 ]
Wang, D [1 ]
Ziebell, MR [1 ]
Sullivan, D [1 ]
Cohen, JB [1 ]
机构
[1] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA
关键词
D O I
10.1021/bi0269815
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
[H-3]4-[(3-trifluoromethyl)-3H-diazirin-3-yl]benzoylcholine (TDBzcholine) was synthesized and used as a photoaffinity probe to map the orientation of an aromatic choline ester within the agonist binding sites of the Torpedo nicotinic acetylcholine receptor (nAChR). TDBzcholine acts as a nAChR competitive antagonist that binds at equilibrium with equal affinity to both agonist sites (K-D similar to 10 muM). Upon UV irradiation (350 nm), nAChR-rich membranes equilibrated with [H-3]TDBzcholine incorporate H-3 into the alpha, gamma, and delta subunits in an agonist-inhibitable manner. The specific residues labeled by [H-3]TDBzcholine were determined by N-terminal sequence analysis of subunit fragments produced by enzymatic cleavage and purified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and/or reversed-phase high-performance liquid chromatography. For the alpha subunit, [H-3]TDBzcholine photoincorporated into alphaCys192, alphaCys-193, and alphaPro-194. For the gamma and delta subunits, [H-3]TDBzcholine incorporated into homologous leucine residues, gammaLeu-109 and deltaLeu-111. The photolabeling of these amino acids suggests that when the antagonist TDBzcholine occupies the agonist binding sites, the Cys- 192-193 disulfide and Pro-194 from the alpha subunit Segment C are oriented toward the agonist site and are in proximity to gammaLeu- 109/deltaLeu-111 in Segment E, a conclusion consistent with the structure of the binding site in the molluscan acetylcholine binding protein, a soluble protein that is homologous to the nAChR extracellular domain.
引用
收藏
页码:271 / 283
页数:13
相关论文
共 50 条
  • [21] Identification of 4-(1H-imidazol-4(5)-ylmethyl)pyridine (immethridine) as a novel, potent, and highly selective histamine H3 receptor agonist
    Kitbunnadaj, R
    Zuiderveld, OP
    Christophe, B
    Hulscher, S
    Menge, WMPB
    Gelens, E
    Snip, E
    Bakker, RA
    Celanire, S
    Gillard, M
    Talaga, P
    Timmerman, H
    Leurs, R
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (10) : 2414 - 2417
  • [22] Discovery of 4-(5-(4-Chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744) as a Novel Positive Allosteric Modulator of the α7 Nicotinic Acetylcholine Receptor
    Faghih, Ramin
    Gopalakrishnan, Sujatha M.
    Gronlien, Jens Halvard
    Malysz, John
    Briggs, Clark A.
    Wetterstrand, Caroline
    Ween, Hilde
    Curtis, Michael P.
    Sarris, Kathy A.
    Gfesser, Gregory A.
    El-Kouhen, Rachid
    Robb, Holly M.
    Radek, Richard J.
    Marsh, Kennan C.
    Bunnelle, William H.
    Gopalakrishnan, Murali
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (10) : 3377 - 3384
  • [23] Exploration of the molecular architecture of the orthosteric binding site in the α4β2 nicotinic acetylcholine receptor with analogs of 3-(dimethylamino)butyl dimethylcarbamate (DMABC) and 1-(pyridin-3-yl)-1,4-diazepane
    Bach, Tinna B.
    Jensen, Anders A.
    Petersen, Jette G.
    Sorensen, Troels E.
    Della Volpe, Serena
    Liu, Jun
    Blaazer, Antoni R.
    van Muijlwijk-Koezen, Jacqueline E.
    Balle, Thomas
    Frolund, Bente
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 102 : 425 - 444
  • [24] Discovery of a Novel 5-HT3 Antagonist/5-HT1A Agonist 3-Amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an Orally Bioavailable Agent for Irritable Bowel Syndrome
    Asagarasu, Akira
    Matsui, Teruaki
    Hayashi, Hiroyuki
    Tamaoki, Satoru
    Yamauchi, Yukinao
    Minato, Kouichi
    Sato, Michitaka
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (21) : 7549 - 7563
  • [25] THE NONCOMPETITIVE BLOCKER [H-3] CHLORPROMAZINE LABELS 3 AMINO-ACIDS OF THE ACETYLCHOLINE-RECEPTOR GAMMA-SUBUNIT - IMPLICATIONS FOR THE ALPHA-HELICAL ORGANIZATION OF REGIONS-MII AND FOR THE STRUCTURE OF THE ION CHANNEL
    REVAH, F
    GALZI, JL
    GIRAUDAT, J
    HAUMONT, PY
    LEDERER, F
    CHANGEUX, JP
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (12) : 4675 - 4679
  • [26] The discovery of 2-fluoro-N-(3-fluoro-4-(5-((4-morpholinobutyl)amino)-1,3,4-oxadiazol-2-yl)phenyl)benzamide, a full agonist of the alpha-7 nicotinic acetylcholine receptor showing efficacy in the novel object recognition model of cognition enhancement
    Skidmore, John
    Atcha, Zeenat
    Boucherat, Emmanuelle
    Castelletti, Laura
    Chen, Deborah W.
    Coppo, Frank T.
    Cutler, Leanne
    Dunsdon, Rachel M.
    Heath, Bronagh M.
    Hutchings, Rio
    Hurst, David N.
    Javed, Sahar
    Martin, Samuel
    Maskell, Emma S. L.
    Norton, David
    Pemberton, Darrel J.
    Redshaw, Sally
    Rutter, Richard
    Sehmi, Sanjeet S.
    Scoccitti, Tiziana
    Temple, Hannah E.
    Theobald, Pam
    Ward, Robert W.
    Wilson, David M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (10) : 3531 - 3534
  • [27] N-[5-(5-Fluoropyridin-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutyramide (SEN78702, WYE-308775): A Medicinal Chemistry Effort toward an α7 Nicotinic Acetylcholine Receptor Agonist Preclinical Candidate
    Zanaletti, Riccardo
    Bettinetti, Laura
    Castaldo, Cristiana
    Ceccarelli, Ilaria
    Cocconcelli, Giuseppe
    Comery, Thomas A.
    Dunlop, John
    Genesio, Eva
    Ghiron, Chiara
    Haydar, Simon N.
    Jow, Flora
    Maccari, Laura
    Micco, Iolanda
    Nencini, Arianna
    Fratelli, Carmela
    Scali, Carla
    Turlizzi, Elisa
    Valacchi, Michela
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (22) : 10277 - 10281
  • [28] Biotransformation of 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl) piperazin-1-yl] butyl} quinazolin-4(3H)-one (TZB-30878), a novel 5-hydroxytryptamine (5-HT)1A agonist/5-HT3 antagonist, in human hepatic cytochrome P450 enzymes
    Minato, Kouichi
    Suzuki, Ryota
    Asagarasu, Akira
    Matsui, Teruaki
    Sato, Michitaka
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (05) : 831 - 840
  • [29] Synthesis of new 4-[2-(4-methyl(amino)sulfonylphenyl)-5-trifluoromethyl-2H-pyrazol-3-yl]-1,2,3,6-tetrahydropyridines:: A search for novel nitric oxide donor anti-inflammatory agents
    Chowdhury, Morshed Alam
    Abdellatif, Khaled R. A.
    Dong, Ying
    Knaus, Edward E.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (19) : 8882 - 8888
  • [30] A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel and selective transient receptor potential type V1 receptor antagonist, blocks channel activation by vanilloids, heat, and acid
    El Kouhen, R
    Surowy, CS
    Bianchi, BR
    Neelands, TR
    McDonald, HA
    Niforatos, W
    Gomtsyan, A
    Lee, CH
    Honore, P
    Sullivan, JP
    Jarvis, MF
    Faltynek, CR
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 314 (01): : 400 - 409